May 6th 2024
Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Male Breast Cancer Survival Similar to That in Women Despite Treatment Variation
July 17th 2020Because male breast cancer is such a rare disease, few strides have been made that convey advantages in its detection, incidence, and mortality. Most treatment guidelines have been extracted from studies performed among female patients.
Read More
Interval Breast Cancer Found Within 1 Year Linked to Worse Mortality
July 14th 2020Breast cancer diagnosed in the year following a negative result after a mammogram has now been associated with an increase in mortality compared with breast cancer detected at a screening, report JAMA Network Open study results.
Read More
Smoking History May Influence Adverse Outcomes Following Radiotherapy for Breast Cancer
July 9th 2020Smoking history can both increase the risk of cancer and create a hypoxic environment within the body, leading to poor outcomes, including less-effective treatment, among patients who undergo radiotherapy.
Read More
Can Early Screening Reduce Breast Cancer Mortality Among Childhood Cancer Survivors?
July 7th 2020In survivors of childhood cancer, early initiation of annual breast cancer screening with MRI, with or without mammography, may reduce breast cancer mortality by half or more, according to a study published in Annals of Internal Medicine.
Read More
Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer
July 1st 2020Despite ongoing disparities in the use of health care services among races/ethnicities and ages, as well as by insurance status, African American women with advanced breast cancer benefited the most following implementation of the Affordable Care Act in states that chose to expand Medicaid coverage.
Read More
Novel Subcutaneous, At-Home Breast Cancer Treatment Approved
June 30th 2020The FDA approved Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf) as a subcutaneous (SC) treatment for adult patients with metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer or early-stage HER-2 positive disease. The treatment combines 2 monoclonal antibodies in a single SC injection.
Read More
Previous Breast Cancer Therapy Not Likely to Affect Outcomes in Patients With COVID-19
June 26th 2020Results from an analysis of patients with breast cancer and coronavirus disease 2019 (COVID-19), from Institut Curie hospitals in France, show that mortality is determined more by comorbidities than previous or current treatment for the cancer.
Read More
Black Women With Insulin Resistance May Have Worse Breast Cancer Prognosis
June 24th 2020Elevated insulin levels, which have been shown to promote tumor growth, due to insulin resistance may be linked to a greater prevalence of invasive breast cancer among black women compared with white women.
Read More
High-Dose Chemo Most Benefits Patients With High-Risk Breast Cancer
June 11th 2020A 20-year follow-up comprising a secondary analysis to an original study shows that high-dose chemotherapy plus hematopoietic stem cell transplant benefit patients with high-risk stage III disease with 10 or more axillary lymph nodes involved.
Read More
Postmenopausal Women With Breast Cancer Show Decreased Brain Health, Cognitive Function
June 8th 2020Previous studies show that up to 75% of women with breast cancer exhibit disease- and treatment-related affects that include poorer cognitive function in the forms of psychological well-being, decision making, and adherence to treatment.
Read More